FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing
October 30, 2008
AVAX Presents Results of a Dose-Response Study of MVax(R) at American Society of Clinical Oncology (ASCO)
June 03, 2008
AVAX Technologies Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax(R))
April 09, 2008
AVAX to Present Results of Phase I-II Study of MVax(R) at 2008 Meeting of the American Society of Clinical Oncology (ASCO)
March 24, 2008
AVAX Technologies Announces Successful Completion of Phase I / II Study of MVax(R) in Patients with Stage 3 and 4 Melanoma
December 10, 2007
AVAX Technologies Appoints Dr. Francois Martelet as President and Chief Executive Officer
December 04, 2007
AVAX Technologies announces the initiation of its Phase III Registration trial of M-Vax(R) in Metastatic Melanoma
November 13, 2007
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here